Table 3:
Predictors of any engagement with psychiatric follow-up 12 months after discharge
Any MD visit |
Any therapist visit |
|||||||
---|---|---|---|---|---|---|---|---|
OR | p-value | 95% CI | OR | p-value | 95% CI | |||
Any relapse 12 months before ending CSC | 0.82 | 0.66 | 0.34 | 1.98 | 1.14 | 0.786 | 0.43 | 3.02 |
Months in CSC | 1.04 | 0.04 | 1.002 | 1.08 | 1.05 | 0.04 | 1.003 | 1.09 |
Non-white race | 0.64 | 0.31 | 0.27 | 1.53 | 2.23 | 0.11 | 0.85 | 5.85 |
Male sex | 0.76 | 0.60 | 0.28 | 2.11 | 0.42 | 0.12 | 0.14 | 1.24 |
Non-English speaking | 0.66 | 0.56 | 0.16 | 2.72 | 0.36 | 0.23 | 0.067 | 1.91 |
#months with antipsychotic fill | 1.064 | 0.32 | 0.94 | 1.2 | 1.04 | 0.58 | 0.91 | 1.18 |
Age at discharge | 1.012 | 0.83 | 0.91 | 1.13 | 0.93 | 0.25 | 0.82 | 1.05 |
Cannabis use at last CSC contact | 0.32 | 0.03 | 0.12 | .90 | 0.53 | 0.26 | 0.17 | 1.6 |
Schizophrenia diagnosis | 0.62 | 0.37 | 0.21 | 1.77 | 0.52 | 0.26 | 0.17 | 1.64 |
Alcohol use at exit | 1.14 | 0.86 | 0.27 | 4.85 | 0.62 | 0.59 | 0.11 | 3.54 |
Insurance | ||||||||
Medicaid | 0.54 | 0.21 | 0.21 | 1.40 | 0.44 | 0.16 | 0.14 | 1.37 |
Medicare | 0.75 | 0.82 | 0.064 | 8.89 | 4.93 | 0.18 | 0.48 | 50.30 |
Private Insurance (comparator) | 1 | . | . | . | 1 | . | . | . |
No insurance | * | . | . | . | 0.97 | 0.98 | 0.09 | 10.68 |
Predicted failure perfectly due to small n (n=6), could not interpret HR